Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hereditary Sensory and Autonomic Neuropathies × avelumab × 90 days × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 8 Carcinoma, Transitional Cell 8 Carcinoma, Renal Cell 5 Carcinoma, Merkel Cell 5 Neoplasms 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Neoplasm Metastasis 3 Melanoma 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Urethral Neoplasms 2 Ureteral Neoplasms 2 Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 2 Skin Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Turcot syndrome 1 Thymoma 1 Sarcoma 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Penile Squamous Cell Carcinoma (PSCC) 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Osteosarcoma 1 Motor Activity 1 Microsatellite Instability 1 Metastatic Urothelial Cancer 1

Interventions

Fulvestrant 3 Letrozole 2 Alpelisib 2 venetoclax 1 tivozanib 1 tipifarnib 1 sotorasib 1 serabelisib 1 sapanisertib 1 ribociclib 1 pembrolizumab 1 palbociclib 1 niraparib 1 exemestane 1 cemiplimab 1 STX-478 1 Radiotherapy 1 Pharmaceutical Preparations 1 Paclitaxel 1 Nivolumab 1 Leuprolide 1 Irinotecan 1 Goserelin 1 Gemcitabine 1 CA-4948 1 Anastrozole 1 AZD1390 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡